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Abstract. The recurrence of the syndromes and multietiological diseases confirms that even a 
small amount of stress or a slight metabolic disequilibrium may be potential disease factors which may 
lead to economic loss. Certain major factors must be taken into account during a survey of potential 
risks for respiratory diseases: the presence of respiratory pathogenic or partially pathogenic viruses, an 
increased number of secondary pathogenic agents, the common bacterial flora, any disequilibrium 
occured in the environment or various immunosupresive factors. 
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INTRODUCTION 
 
In case of any syndrome, the control strategy should include not only the primary 
pathogenic factors  but also the secondary ones – such as environmental conditions. 
Vaccination represents the most effective control method; it must be implemented in all farms 
with previous pathological cases. Both reduced live vaccines and the non-activated ones are 
the most efficient vaccination strategies in case of reproduction and laying poultry (1,2,3,4). 
  The tested product is recommended for the  active immunization of laying hens, 
against Newcastle disease, infectious bronchitis, egg drop syndrome and rhinotracheitis in 
poultry as a booster effect (1,5,6). 
The vaccine is to be used for the laying poultry 2 – 4 weeks before the laying period. 
The dose is 0.3 ml in intramuscular vaccination protocol (in the chest or thigh muscle) or 
subcutaneous vaccination protocol (in the lower part of the neck). 
The poultry will initially be vaccinated with a live vaccine against infectious 
bronchitis, Newcastle disease, and rhinotracheitis in poultry in order to obtain a booster effect. 
There is no need to initially use a live vaccine against egg drop syndrome. The best results are 
obtained if vaccination with non-activated vaccine is performed after at least four weeks since 
the live vaccination protocol. Only healthy poultry shall be vaccinated (6,7). 
The clinical testation of the immunologic product GALLIMUNE 407 ND+IB 
+EDS+ART, for the active immunization of poultry against the Newcastle disease, infectious 
bronchitis, egg drop syndrom and rhinotracheitis in poultry was performed in farm conditions 
on a lot of 42,000 animals, reproductive youth, heavy races, the Ross 308 hybride, aged 18 
weeks. 
 
MATHERIALS AND METHODS 
 
The used vaccine is GALLIMUNE 407 ND+IB +EDS+ART, lot: F38587. The 
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vaccine protocol was 0.3 ml per individual, intramuscular injection. There were taken 55 
blood samples as follows: before vaccination, 28 days and 56 days after vaccination – for the 
determination of the poultry immune status before and after vaccination. The poultry was 
daily examined by specialists, during the entire 56 days’ period. 
 
Tab. 1: 
The vaccination schedule for the test stock 
 
No 
  
Poultry Age 
  
The Administered Biological Product  
  
Way of administering 
1.  1 day  Vaccine against Marek disease  Subcutaneous 
injection 
2. 5 days  Vaccine against avian coccidiosis  In drinking water 
3.  8 days  Vaccine against avian reovirosis and salmonelosis  Subcutaneous 
injection 
4.  9 days  Vaccine against the Newcastle disease (I), 
infectious bronchitis (I) 
 In drinking water 
5.  11 days  Vaccine against avian infectious bursitis   In drinking water 
 
6.  21 days  Vaccine against the Newcastle disease (II), 
infectious bronchitis (II) 
 In drinking water 
7.  33 days  Vaccinee against mycoplasmosis (I) - 
 
8.  42 days  Vaccinee against avian rhinotracheitis  In drinking water 
 
9.  48 days  Vaccine against avian reovirosis and salmonelosis  Subcutaneous 
injection 
10.  54days  Vaccine against the Newcastle disease (III), 
infectious bronchitis (III) 
 In drinking water 
11.  66 days  Vaccinee against mycoplasmosis (II) - 
12.  73 days  Vaccine against avian encephalomyelitis and 
diphtero-variola 
 
Stick  
13.  89 days  Vaccine against the Newcastle disease (IV), 
infectious bronchitis (IV) 
 In drinking water 
14.  109 days  Vaccine against salmonelosis  Subcutaneous 
injection 
 
 
RESULTS AND DISCUSSIONS 
 
At the end of the test period, the folowing aspects were ascertained: 
- The vaccine was well tolerated, with no general reactions due to the product; 
- The mortality rate was within the technological limits; 
- There were no infectious, contagious or intercurrent diseases to determine technological loss 
to the livestock. 
The induced immune feed-back pursuant to administering GALLIMUNE 407 
ND+IB+EDS+ART was determined by the hemagglutination-inhibition reaction (ND) and the 
immunoenzymatic test – ELISA, using the kits of Laboratorios Hipra S.A.: „CIVTEST AVI 
IBV”, lot: CIB.2K8W, validity: 08.2007 (component IB),  „CIVTEST AVI EDS”, lot: 
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CED.1Z8W, validity: 05.2007(for component EDS) şi „CIVTEST AVI TRT”, lot: 
CTR.1P9R, validity: 02.2007 (for TRT). 
The serum samples were processed according to kit instructions; the reaction reading 
(after stopping) was performed under λ = 405 nm. 
The results reading was performed in accordance with the kit instructions – according 
to which ELISA titres, greater than 269 UE (for IB), 922 UE (for EDS) and 196 UE (for TRT) 
indicate a positive reaction. 
 
Tab.2: 
The following antibody titres were obtained after the vaccination 
 
  
Livestock 
Vaccinated with 
GALLIMUNE 
201 IBD+REO 
 
  
 
T0 – before the vaccine 
protocol 
  
 
T1 – 28 days after the 
vaccine protocol 
  
 
T2 – 56 days after the 
vaccine protocol 
ND 1/4 – 1/32  1/256 – 1/1024 1/512- 1/1024 
IB 5116 U.E. 4671 U.E. 5978 U.E. 
EDS 73 U.E. 926 U.E. 1350 U.E. 
TRT 5011 U.E. 8722 U.E. 9649 U.E. 
  
  
The antibody titres before and after the vaccine protocol, pursuant to 
administering the immunologic product, against infectious bursitis and avian 
reovirosis „ Gallimune 407 ND+IB+EDS+ART” are shown in diagrams 1,2,3,4. 
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Diagram 1: Immune feed-back 28 and 56 days after the vaccine protocol  „ Gallimune 407 ND+IB+EDS+ART” 
– component IB. 
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Diagram 2: Immune feed-back 28 and 56 days after the vaccine protocol  „ Gallimune 407 ND+IB+EDS+ART” 
– component TRT. 
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Diagram 3: Immune feed-back 28 and 56 days after the vaccine protocol  „ Gallimune 407 ND+IB+EDS+ART” 
– component EDS. 
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Diagram 4: Immune feed-back before and 28 and 56 days after the vaccine protocol  „Gallimune 407 
ND+IB+EDS+ART” – component ND. 
 
CONCLUSIONS 
 
• The immunological product Gallimune 407 ND+IB+EDS+ART has a good innocuity; 
there are no local and / or general reactions; 
• The immune feed-back induced by the vaccine is suitable; values higher than the 
minimum positive level are registered; 
• After a 28 days’ period after the vaccination protocol, the antibody titre has the following 
values: 1/256-1/1024, for ND,5116 U.E. for IB, 8722 U.E., for TRT and 1350 U.E., for 
EDS. 
• At the end of the monitoring period (56 days) of the vaccinated livestock, the antibody 
titre values reach a very high average level:  ( ND= 1/512-1/1024, IB= 5978 U.E., TRT= 
9649 U.E. and EDS=1350 U.E ). 
• During the entire test period, there are no intercurrent diseases; the mortality rate value is 
within the accepted technological values for such a category. 
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